This year (in May, 2016) the US Food and Drug Administration (FDA) in cooperation with drug distributor Takeda Pharmaceuticals has changed the brand name of the antidepressant Brintellix to Trintellix. The generic name vortioxetine remains the same. The name change was made because of continued prescribing and dispensing errors with a completely different blood-thinning drug called Brilinta.
Of course, we don’t recommend taking the drug regardless of what it is called. It supposed to be prescribed for something called “major depressive disorder [MDD].” In practice, it is just another SSRI, messing with the levels of serotonin in the brain. To quote from the manufacturer’s Medication Guide, “The mechanism of the antidepressant effect of vortioxetine is not fully understood.”
Interestingly enough, one of the potential side effects is actually called “Serotonin Syndrome,” whose symptoms may include agitation, hallucinations, delirium, coma, tachycardia, labile blood pressure, dizziness, diaphoresis, flushing, hyperthermia, tremor, rigidity, myoclonus, hyperreflexia, incoordination, seizures, nausea, vomiting, and diarrhea.
“Pooled analyses of shortterm placebo-controlled studies of antidepressant drugs (selective serotonin reuptake inhibitors
[SSRIs] and others) showed that these drugs increase the risk of suicidal thinking and behavior (suicidality) in children, adolescents, and young adults (ages 18 to 24) with MDD and other psychiatric disorders.”
See our previous blog on Brintellix for more information.
See this also for more information.
We must recognize that the real problem is that psychiatrists and other medical practitioners fraudulently diagnose life’s problems as an “illness” and stigmatize unwanted behavior as “diseases.” Psychiatry’s stigmatizing labels, programs and treatments are harmful junk science; their diagnoses of “mental disorders” are a hoax – unscientific, fraudulent and harmful.
CCHR believes that everyone has the right to full informed consent. FIND OUT! FIGHT BACK!